Competing Interests: The authors

Background Hematopoietic stem cells (HSCs) or repopulating cells are able to self-renew and differentiate into cells of all hematopoietic lineages, and they can be enriched using the CD34 cell surface marker. Because of this unique property, HSCs have been used for HSC transplantation and gene therapy applications. However, the inability to expand HSCs has been a significant limitation for clinical applications. Here we examine, in a clinically relevant nonhuman primate model, the ability of HOXB4 to expand HSCs to potentially overcome this limitation. Methods and Findings Using a competitive repopulation assay, we directly compared in six animals engraftment of HOXB4GFP (HOXB4 green fluorescent protein) and control (yellow fluorescent protein [YFP])–transduced and expanded CD34 + cells. In three animals, cells were infused after a 3-d transduction culture, while in three other animals cells were infused after an additional 6–9 d of ex vivo expansion. We demonstrate that HOXB4 overexpression resulted in superior engraftment in all animals. The most dramatic effect of HOXB4 was observed early after transplantation, resulting in an up to 56-fold higher engraftment compared to the control cells. At 6 mo after transplantation, the proportion of marker gene–expressing cells in peripheral blood was still up to 5-fold higher for HOXB4GFP compared to YFP-transduced cells. Conclusions These data demonstrate that HOXB4 overexpression in CD34 + cells has a dramatic effect on expansion and engraftment of short-term repopulating cells and a significant, but less pronounced, effect on long-term repopulating cells. These data should have important implications for the expansion and transplantation of HSCs, in particular for cord blood transplantations where often only suboptimal numbers of HSCs are available.

[1]  Marie Clark,et al.  Where Can I Get More Information , 2006 .

[2]  M. Gordon.  Transplants of Umbilical-Cord Blood or Bone Marrow From Unrelated Donors in Adults With Acute Leukemia , 2006 .

[3]  K. Ballen.  New trends in umbilical cord blood transplantation. , 2005, Blood.

[4]  T. Neff,et al.  Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. , 2005, Blood.

[5]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[6]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[7]  S. Vercauteren,et al.  Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo. , 2004, Blood.

[8]  J. Krosl,et al.  Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. , 2004, Blood.

[9]  I. Mcniece.  Ex vivo expansion of hematopoietic cells. , 2004, Experimental hematology.

[10]  T. Neff,et al.  Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  S. Riddell,et al.  Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. , 2004, Blood.

[12]  David A. Williams,et al.  Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. , 2003, The Journal of clinical investigation.

[13]  J. Krosl,et al.  In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein , 2003, Nature Medicine.

[14]  H. Kiem,et al.  Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells. , 2003, Blood.

[15]  P. Romeo,et al.  Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein , 2003, Nature Medicine.

[16]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[17]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[18]  B. Aronow,et al.  Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates , 2003, Nature Medicine.

[19]  A. Rimek,et al.  High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. , 2003, Blood.

[20]  M. Yamaguchi,et al.  Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. , 2003, Blood.

[21]  D. Harlan,et al.  Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. , 2002, Blood.

[22]  S. Riddell,et al.  Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. , 2002, Blood.

[23]  G. Sauvageau,et al.  Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. , 2002, Blood.

[24]  G. Sauvageau,et al.  HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo , 2002, Cell.

[25]  J. Koevoet,et al.  Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells , 2001, Leukemia.

[26]  I. Bernstein,et al.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling , 2000, Nature Medicine.

[27]  D. Lauffenburger,et al.  A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. , 2000, Blood.

[28]  T. Oegema,et al.  Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. , 2000, Blood.

[29]  J. Dick,et al.  Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. , 2000, Blood.

[30]  J. Dick,et al.  Bone Morphogenetic Proteins Regulate the Developmental Program of Human Hematopoietic Stem Cells , 1999, The Journal of experimental medicine.

[31]  M. Byrne,et al.  Dissecting the Marrow Microenvironment , 1999, Annals of the New York Academy of Sciences.

[32]  J. Rasko,et al.  Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. , 1998, Blood.

[33]  E. Blokland,et al.  Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells , 1998 .

[34]  E. Blokland,et al.  Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. , 1998, Blood.

[35]  J. Dick,et al.  Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture , 1997, The Journal of experimental medicine.

[36]  J M Piret,et al.  Cytokine manipulation of primitive human hematopoietic cell self-renewal. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Hawley,et al.  Versatile retroviral vectors for potential use in gene therapy. , 1994, Gene therapy.